Telesis Bio (TBIO) Short Interest Ratio & Short Volume → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free TBIO Stock Alerts $0.32 +0.01 (+3.24%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Telesis Bio Short Interest DataCurrent Short Volume105,100 sharesPrevious Short Volume100,400 sharesChange Vs. Previous Month+4.68%Dollar Volume Sold Short$39,696.27Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares30,100,000 sharesFloat Size8,780,000 sharesShort Percent of Float1.20%Today's Trading Volume1,326,753 sharesAverage Trading Volume584,356 sharesToday's Volume Vs. Average227% Short Selling Telesis Bio ? Sign up to receive the latest short interest report for Telesis Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTBIO Short Interest Over TimeTBIO Days to Cover Over TimeTBIO Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Telesis Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024105,100 shares $39,696.27 +4.7%1.2%0.1 $0.38 3/31/2024100,400 shares $44,176.00 -55.6%1.1%0.1 $0.44 3/15/2024226,300 shares $117,449.70 -33.8%2.6%0.3 $0.52 2/29/2024341,800 shares $190,895.30 +160.1%3.9%0.5 $0.56 2/15/2024131,400 shares $40,773.42 -17.4%1.5%0.1 $0.31 1/31/2024159,100 shares $52,662.10 -66.9%1.8%0.6 $0.33 Get the Latest News and Ratings for TBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024481,200 shares $168,275.64 -2.9%5.5%1.8 $0.35 12/15/2022133,300 shares $159,960.00 -42.6%1.6%1.8 $1.20 11/30/2022232,100 shares $336,545.00 -28.7%2.7%3.1 $1.45 11/15/2022325,700 shares $543,919.00 +22.7%3.8%4.4 $1.67 10/31/2022265,400 shares $429,948.00 +12.3%3.1%2.4 $1.62 10/15/2022236,300 shares $444,244.00 +26.5%2.7%1.7 $1.88 9/30/2022186,800 shares $310,088.00 -1.3%2.1%1 $1.66 9/15/2022189,300 shares $401,316.00 -28.9%2.2%0.5 $2.12 8/31/2022266,400 shares $511,488.00 -43.6%3.1%0.5 $1.92 8/15/2022472,600 shares $1.12 million +39.5%5.5%0.8 $2.36 7/31/2022338,900 shares $647,299.00 +0.6%3.9%0.6 $1.91 7/15/2022336,900 shares $572,730.00 -54.3%3.9%0.6 $1.70 6/30/2022736,400 shares $1.33 million -7.7%8.5%1.3 $1.80 6/15/2022797,700 shares $2.16 million -21.8%9.2%1.6 $2.71 5/31/20221,020,000 shares $4.06 million +23.0%11.7%3.6 $3.98 5/15/2022829,200 shares $3.16 million -17.1%9.5%2.8 $3.81 4/30/20221,000,000 shares $3.70 million -27.0%11.5%3 $3.70 4/15/20221,370,000 shares $6.26 million -30.8%15.8%4 $4.57 3/31/20221,980,000 shares $10.63 million +37.5%22.8%5.2 $5.37 3/15/20221,440,000 shares $13.26 million -19.1%16.6%2.2 $9.21 2/28/20221,780,000 shares $18.16 million +24.5%20.5%3 $10.20 2/15/20221,430,000 shares $13.83 million -29.2%16.5%2.4 $9.67 1/31/20222,020,000 shares $15.84 million -3.4%23.3%3.6 $7.84 1/15/20222,090,000 shares $15.76 million +104.9%24.1%3.9 $7.54 12/31/20211,020,000 shares $11.02 million +87.7%11.8%2.1 $10.80 12/15/2021543,500 shares $3.64 million +10.4%6.3%6.3 $6.70 11/30/2021492,400 shares $3.37 million +8.0%5.7%4.9 $6.84 11/15/2021456,000 shares $3.71 million -0.3%5.3%4.2 $8.13 10/29/2021457,200 shares $4.22 million -8.1%5.3%4.6 $9.24 10/15/2021497,400 shares $5.41 million +1.8%5.7%4.6 $10.87 9/30/2021488,600 shares $5.44 million +37.1%5.6%4 $11.13 9/15/2021356,400 shares $4.55 million -12.0%4.1%2.6 $12.77 8/31/2021404,900 shares $5.25 million -10.3%5.1%2.1 $12.97 8/13/2021451,600 shares $6.20 million No Change5.7%2.1 $13.72Could this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. TBIO Short Interest - Frequently Asked Questions What is Telesis Bio's current short interest? Short interest is the volume of Telesis Bio shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 105,100 shares of TBIO short. 1.20% of Telesis Bio's shares are currently sold short. Learn More on Telesis Bio's current short interest. What is a good short interest percentage for Telesis Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.20% of Telesis Bio's floating shares are currently sold short. Is Telesis Bio's short interest increasing or decreasing? Telesis Bio saw a increase in short interest in April. As of April 15th, there was short interest totaling 105,100 shares, an increase of 4.7% from the previous total of 100,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Telesis Bio's float size? Telesis Bio currently has issued a total of 30,100,000 shares. Some of Telesis Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Telesis Bio currently has a public float of 8,780,000 shares. How does Telesis Bio's short interest compare to its competitors? 1.20% of Telesis Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Telesis Bio: Precipio, Inc. (0.41%), Talis Biomedical Co. (0.74%), Accelerate Diagnostics, Inc. (2.90%), Cue Health Inc. (0.52%), Singular Genomics Systems, Inc. (1.42%), Rapid Micro Biosystems, Inc. (0.33%), Biomerica, Inc. (0.39%), PHAXIAM Therapeutics S.A. (0.01%), Mainz Biomed (2.30%), Novo Integrated Sciences, Inc. (6.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Telesis Bio stock? Short selling TBIO is an investing strategy that aims to generate trading profit from Telesis Bio as its price is falling. TBIO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Telesis Bio? A short squeeze for Telesis Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TBIO, which in turn drives the price of the stock up even further. How often is Telesis Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PRPO Short Interest TLIS Short Interest AXDX Short Interest HLTH Short Interest OMIC Short Interest RPID Short Interest BMRA Short Interest PHXM Short Interest MYNZ Short Interest NVOS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TBIO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold